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تعفن بكتريي ضخم يف األذين األمين ملريض غسيل كلى بالقسطرة تعفن 
الدم بالستافيلوكوكاس متعلق بالقسطرة
 جيب إزالة أنبوب القسطرة عند عدم استعماله
برا�شانث باندوراجنا و حممد املخيني
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A 57-year-old woman who wasdiabetic and hypertensive, with a history of end-stage renal disease and on regular 
haemodialysis was referred from a regional hospital 
with fever and leucocytosis. She was receiving 
dialysis through an arteriovenous fistula (AVF), 
initially created 8 months prior to the present 
admission. However, after 3 months, the patient 
developed recurrent haematoma and stenosis of the 
fistula, necessitating an angioplasty. At that time a 
tunnelled dialysis catheter (TDC) (QUINTON™ 
PERMCATH™ Dual Lumen Catheter, Covidien, 
Mansfield, Massachusetts, USA) was inserted in the 
right internal jugular vein. Dialysis was continued 
uneventfully using the TDC for approximately one 
month. For the following 3-month period the patient 
returned to using the AVF. However, the TDC was 
left in situ. Upon admission, 3 blood cultures drawn 
from the TDC and one from the peripheral blood 
were confirmed to be positive for methicillin-
sensitive Staphylococcus aureus. A transthoracic 
echocardiogram showed multiple masses in the 
right atrium suggestive of vegetation. The TDC 
was removed as the tip of the catheter grew S. 
aureus. The patient was treated with flucloxacillin 
and vancomycin, with a trough vancomycin level 
 
Figure 1 A & B: (A) Transoesophageal echocardiogram demonstrating the presence of large vegetation attached to the 
right atrial wall in a patient with a tunnelled dialysis catheter-related staphylococcal sepsis (arrowheads); (B) Multi-
lobulations typical of staphylococcal bacteremia (arrowheads). 
RA = right atrium; LA = left atrium; RV = right ventricle.
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of 18 µg/mL (target 15–20). The transoesophageal 
echocardiogram showed a large lobulated mobile 
mass in the right atrium, attached to the free wall 
just near the inferior vena cava. It measured 35 x 
15 mm prolapsing into the tricuspid valve but with 
no significant obstruction [Figure 1]. There were 
no vegetations on the valves. High-risk open heart 
surgery was offered to the patient but was refused. 
The patient subsequently went into a refractory 
sepsis and did not survive. 
The occurrence of a catheter-related 
bloodstream infection (CRBI) in patients on 
haemodialysis has been found to beindependently 
associated with increased mortality.1 A report from 
the US Renal Data System (USRDS) database states 
that infection is the second most common cause 
of mortality in end-stage renal disease (ESRD), the 
first being cardiovascular events.2 A TDC-related 
infection can occur either at the exit site, within 
the tunnel and/or in the bloodstream (CRBI). 
Cases of CRBI are reported to have a mortality rate 
of 12–25%.3 The Centers for Disease Control and 
Prevention (CDC) in the USA recommend that 
the primary prevention strategy is the avoidance 
of central lines in favor of AVFs, for instance, as 
recommended in the Fistula First Breakthrough 
Initiative.3 Additionally, when catheters are used, 
the recommended interventions to improve 
central-line maintenance can reduce CRBI in 
patients undergoing haemodialysis.3 Furthermore, 
the CDC stress the need for the prompt removal 
of unused or unneeded central lines.3 TDCs have a 
reported infection rate of 1.6–5.5 cases every 1,000 
days.4 The Vascular Access Work Group Clinical 
Practice Guidelines for vascular access recommend 
important central-line maintenance measures: 1) 
staff manipulating catheters should wear masks and 
clean or sterile disposable gloves; 2) the need for 
meticulous skin preparation during the insertion 
and application of exit site cleaning solutions; 3) 
the application of non-occlusive dressings; 4) the 
application of topical antibiotic ointment at catheter 
exit sites; 5) the use of prophylactic antimicrobial 
locking solutions; 6) catheters should be coated with 
antimicrobial agents or heparin, and 7) the training 
of nurses and patient in the proper maintenance of 
central-lines.4 
Catheter exit-site infections should be treated 
with topical and oral antibiotics without the need 
for catheter replacement. However, CRBI requires 
the administration of the appropriate systemic 
antibiotics (for a minimum of 3 weeks). The catheter 
should also either be removed with a delayed 
replacement (particularly for unstable patients, or 
those with a persistent fever lasting >48 hours), or 
the catheter should be exchanged over the wire, 
or it should be salvaged with antibiotic locking 
solutions, depending on the clinical situation. In 
the case of tunnel-tract infections, the appropriate 
response is the removal of the catheter. 
This case indicates that if a TDC is used in 
patients with end-stage renal disease, the catheter 
needs to be removed as soon as medically possible. 
In addition, national guidelines as initiated by the 
CDC3 or the Vascular Access Work Group4 need to 
be developed and employed in Oman. 
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